Effect of Nimodipine Treatment on the Clinical Course of Reversible Cerebral Vasoconstriction Syndrome
Background: In reversible cerebral vasoconstriction syndrome (RCVS), nimodipine is currently used for the treatment, although no evidence is available to support its disease-modifying effect. In this prospective observational study, we investigated whether earlier nimodipine treatment can modify the...
Main Authors: | Soohyun Cho, Mi Ji Lee, Chin-Sang Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00644/full |
Similar Items
-
Reversible Cerebral Vasoconstriction Syndrome Induced by Pseudoephedrine
by: Dong Hyun Lee, et al.
Published: (2016-06-01) -
Nimodipine-refractory reversible cerebral vasoconstriction syndrome treated effectively with verapamil
by: So Young Park, et al.
Published: (2020-12-01) -
Reversible cerebral vasoconstriction syndrome: literature review
by: Michelle Zonkowski Ribas, et al.
Published: (2023-01-01) -
Reversible Cerebral Vasoconstriction Syndrome after Nifedipine Withdrawal
by: Mohammed H. Alanazy, et al.
Published: (2020-11-01) -
Headache Attributed to Reversible Cerebral Vasoconstriction Syndrome (RCVS)
by: Vasileios Tentolouris-Piperas, et al.
Published: (2023-08-01)